SILVER GRAIL RESOURCES LTD. (GRAL)
GRAL INVESTOR ALERT: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- Hagens Berman
GRAL INVESTOR ALERT: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- Hagens Berman
VINCI: Excellent financial performance in the first half of 2026
Alamar Biosciences 推出 NULISAseq™ Immune 340 Panel,实现免疫蛋白质组全面分析
Alamar Biosciences 推出 NULISAseq™ Immune 340 Panel 檢測組合,為免疫蛋白質體作全面分析
VINCI : Excellente performance économique au S1 2026
La crème Opzelura® (ruxolitinib) devient le premier inhibiteur de JAK topique sans stéroïdes autorisé dans l'Union européenne pour le traitement des adultes atteints de dermatite atopique modérée
A meeting convened for 6.8.26 is postponed to 6.8.26 - correction
Kimball Electronics, Inc. Announces Date For Reporting Fourth Quarter and Fiscal Year 2026 Financial Results
Riassunto: Compass Pathways annuncerà i risultati finanziari del secondo trimestre e della prima metà del 2026 il 5 agosto 2026
Compass Pathways gibt am 5. August 2026 die Finanzergebnisse für das zweite Quartal und das erste Halbjahr 2026 bekannt